Skip to content

Search

Showing results for "early lung health"

Assistance and Companion Dogs for children diagnosed with Autism Spectrum Disorder and Fragile X

Andrew Gail Videos Whitehouse Watch and listen to Andrew Alvares PhD PhD Deputy Director (Research); Angela Wright Bennett Professor of Autism

Characterising the epidemiology of RSV in Australian children through record linkage: clinical burden, outcomes and risk factors

Hannah Peter Moore Richmond OAM BSc (Hons) GradDipClinEpi PhD MBBS MRCP(UK) FRACP Head, Infectious Diseases Research Head, Vaccine Trials Group 08

Epidemiology of craniofacial anomalies and association with intellectual disabilities in Western Australia: A population based study

Helen Mohammed Leonard Junaid MBChB MPH BDS, MDS, MFDS RCPS (Glasg.), DDPH RCS (Eng) Principal Research Fellow Honorary Team Member +61 419 956 946

Mothers with intellectual disability and their children in Western Australia

Helen Leonard MBChB MPH Principal Research Fellow +61 419 956 946 helen.leonard@thekids.org.au Principal Research Fellow Areas of research expertise

The Proactive Study

Andrew Gail Videos Whitehouse Watch and listen to Andrew Alvares PhD PhD Deputy Director (Research); Angela Wright Bennett Professor of Autism

Understanding the true burden of paediatric respiratory syncytial virus (RSV) in order to optimise prevention programs

Hannah Moore OAM BSc (Hons) GradDipClinEpi PhD Head, Infectious Diseases Research 08 6319 1427 Hannah.moore@thekids.org.au Head, Infectious Diseases

AusVaxSafety (previously FAST)

The aim of the study is the early identification of problems with the current flu vaccines, and providing parents and professionals with up to date information.

Recruitment of active participants comes to an end for ORIGINS

ORIGINS has officially reached the study's five-year goal of recruiting 4,000 active participants to the project and has closed recruitment of new families into the active cohort.

Childhood Leukaemia

Assessing efficacy of infant T-cells to develop child-specific cancer immunotherapies.